2050 Capital
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United kingdom
Investment stages
- Pre-Seed
- Seed
Industries
- AI
- Transportationtech
- Biotech
- Enterprise
- Cloud Infrastructure
- Climatetech
- Deeptech
About
2050 Capital is an earlystage venture capital firm specializing in deep tech and scientific investments. The firm applies a disciplined and surgical investment approach, backed by indepth due diligence. 2050 Capital typically invests $200500k in seed rounds and up to $3 M in followon investments, with a track record of over 50% in followon investments. The firm supports its portfolio companies with business development, strategy, and nextstage fundraising from the initial investment onward. Notable investments include companies such as AMFG, Blackrock Neurotech, ChAI, Hadean, KETS, Origin Sciences, Snyk, Vaticle, and OSCP.
2050 Capital is an earlystage venture capital firm specializing in deep tech and scientific investments. The firm applies a disciplined and surgical investment approach, backed by indepth due diligence. 2050 Capital typically invests $200500k in seed rounds and up to $3 M in followon investments, with a track record of over 50% in followon investments. The firm supports its portfolio companies with business development, strategy, and nextstage fundraising from the initial investment onward. Notable investments include companies such as AMFG, Blackrock Neurotech, ChAI, Hadean, KETS, Origin Sciences, Snyk, Vaticle, and OSCP.
Investment Thesis
2050 Capital invests in transformative and defensible innovation that impacts large fundamental sectors, focusing on enterprise software (with a deep science component), computational biotech, and engineering and science ventures.
Team
Andreas Roelofs (Managing Partner)
Joshua Gilbert (Partner)
Portfolio
Origin
Blackrock Neurotech
KETS Quantum Security
One Silicon Chip Photonics
ChAI (Business/Productivity Software)
Hadean
Biofourmis
Paradromics
Neuroglee Health
Vaticle